IBDEI18A ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20530,1,3,0)
 ;;=3^Prostate Cyst
 ;;^UTILITY(U,$J,358.3,20530,1,4,0)
 ;;=4^N42.83
 ;;^UTILITY(U,$J,358.3,20530,2)
 ;;=^322241
 ;;^UTILITY(U,$J,358.3,20531,0)
 ;;=N52.9^^97^964^13
 ;;^UTILITY(U,$J,358.3,20531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20531,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,20531,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,20531,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,20532,0)
 ;;=R39.89^^97^964^15
 ;;^UTILITY(U,$J,358.3,20532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20532,1,3,0)
 ;;=3^Genitourinary System Symptoms/Signs NEC
 ;;^UTILITY(U,$J,358.3,20532,1,4,0)
 ;;=4^R39.89
 ;;^UTILITY(U,$J,358.3,20532,2)
 ;;=^5019350
 ;;^UTILITY(U,$J,358.3,20533,0)
 ;;=R39.2^^97^964^14
 ;;^UTILITY(U,$J,358.3,20533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20533,1,3,0)
 ;;=3^Extrarenal Uremia
 ;;^UTILITY(U,$J,358.3,20533,1,4,0)
 ;;=4^R39.2
 ;;^UTILITY(U,$J,358.3,20533,2)
 ;;=^5019348
 ;;^UTILITY(U,$J,358.3,20534,0)
 ;;=R30.1^^97^964^29
 ;;^UTILITY(U,$J,358.3,20534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20534,1,3,0)
 ;;=3^Vesical Tenesmus
 ;;^UTILITY(U,$J,358.3,20534,1,4,0)
 ;;=4^R30.1
 ;;^UTILITY(U,$J,358.3,20534,2)
 ;;=^5019323
 ;;^UTILITY(U,$J,358.3,20535,0)
 ;;=Z85.46^^97^964^16
 ;;^UTILITY(U,$J,358.3,20535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20535,1,3,0)
 ;;=3^Hx of Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,20535,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,20535,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,20536,0)
 ;;=N18.1^^97^964^4
 ;;^UTILITY(U,$J,358.3,20536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20536,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,20536,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,20536,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,20537,0)
 ;;=N18.2^^97^964^5
 ;;^UTILITY(U,$J,358.3,20537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20537,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,20537,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,20537,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,20538,0)
 ;;=N18.3^^97^964^6
 ;;^UTILITY(U,$J,358.3,20538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20538,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,20538,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,20538,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,20539,0)
 ;;=N18.4^^97^964^7
 ;;^UTILITY(U,$J,358.3,20539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20539,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,20539,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,20539,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,20540,0)
 ;;=N18.5^^97^964^8
 ;;^UTILITY(U,$J,358.3,20540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20540,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,20540,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,20540,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,20541,0)
 ;;=N18.6^^97^964^10
 ;;^UTILITY(U,$J,358.3,20541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20541,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,20541,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,20541,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,20542,0)
 ;;=N18.9^^97^964^9
 ;;^UTILITY(U,$J,358.3,20542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20542,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,20542,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,20542,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,20543,0)
 ;;=N17.8^^97^964^1
 ;;^UTILITY(U,$J,358.3,20543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20543,1,3,0)
 ;;=3^Acute Kidney Failure,Other
 ;;^UTILITY(U,$J,358.3,20543,1,4,0)
 ;;=4^N17.8
